de Lint, Klaas <br/><br/>
Sensitizing Triple-Negative Breast Cancer to PI3K Inhibition by Cotargeting IGF1R.  [electronic resource] 

 -  Molecular cancer therapeutics  07 2016 
 - 1545-56 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1538-8514 
<br/><br/><label>Standard No.: </label>10.1158/1535-7163.MCT-15-0865  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Dose-Response Relationship, Drug<br/>Drug Resistance, Neoplasm--genetics<br/>Female<br/>Gene Expression<br/>Gene Knockdown Techniques<br/>Humans<br/>Indazoles--pharmacology<br/>Phosphoinositide-3 Kinase Inhibitors<br/>Protein Kinase Inhibitors--pharmacology<br/>Receptor, IGF Type 1--antagonists & inhibitors<br/>Signal Transduction--drug effects<br/>Sulfonamides--pharmacology<br/>Triple Negative Breast Neoplasms--genetics